variable | Non-adjusted Model | Adjusted Model |
---|
P-value | OR (95% CI) | P-value | OR (95% CI) |
---|
Male | Q1* | - | - | - | - |
Q2* | 0.248 | 0.836(0.618–1.133) | 0.572 | 0.903(0.633–1.288) |
Q3* | 0.004 | 0.629(0.459–0.861) | 0.027 | 0.664(0.462–0.955) |
Q4* |  < 0.001 | 0.442(0.317–0.616) | 0.001 | 0.513(0.349–0.753) |
Female | Q1# | - | - | - | - |
Q2# | 0.002 | 0.666(0.514–0.864) | 0.037 | 0.729(0.542–0.982) |
Q3# | 0.001 | 0.653(0.504–0.848) | 0.001 | 0.593(0.436–0.805) |
Q4# | 0.001 | 0.645(0.497–0.837) |  < 0.001 | 0.477(0.348–0.652) |
- Note:Adjusted model:adjusted age, ethnic groups, GDS score, sleeping quality, education level, cognitive function, smoking history, drinking history, ADL score, and chronic disease(hypertension, diabetes, coronary heart disease, chronic obstructive pulmonary disease, osteoarthropathy, liver disease, gastrointestinal disease, stroke history). In female: Q1# < 253.85umol/l, 253.85umol/l ≤ Q2# < 293.8umol/l, 293.8umol/l ≤ Q3# < 340.4umol/l, 340.4umol/l ≤ Q4#; In male: Q1* < 319.2umol/l, 319.2umol/l ≤ Q2* < 372.25umol/l, 372.25umol/l ≤ Q3* < 423.525umol/l, 423.525umol/l ≤ Q4*. The odds ratios (OR) represent the odds of sarcopenia with the first quartile of UA as the baseline category